Drreddys Laboratories reported INR519.54B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
ANI Pharmaceuticals USD 1.34B 50.57M Jun/2025
Aurora Cannabis CAD 837.84M 28.68M Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Canopy Growth CAD 904.67M 259.55M Jun/2025
Cipla INR 373.87B 27.32B Mar/2025
Corcept Therapeutics USD 801.72M 44.73M Jun/2025
Drreddys Laboratories INR 519.54B 38.48B Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Hikma Pharmaceutical USD 5.13B 286M Dec/2024
Lonza CHF 19.73B 1.85B Dec/2024
Novartis USD 104.4B 4.45B Jun/2025
Pacira USD 1.54B 49.41M Jun/2025
Prestige Brands USD 3.43B 29.41M Jun/2025
Richter Gedeon HUF 1.6T 116.26B Dec/2024
Sun Pharmaceuticals INR 921.01B 39.85B Mar/2025
Supernus Pharmaceuticals USD 1.38B 35.11M Jun/2025
Teva Pharmaceutical Industries USD 40.13B 1.72B Jun/2025